Story perspectives

GSK Uses 88 Million Patient Records for Vaccine Development

By Drooid · Sep 14, 2026, 10:23 AM UTC · How we work

Summary

Story summary

GSK is using Greater Bay Area patient data to accelerate vaccine and cancer drug development.
The data pool covers 88 million residents across 11 cities, enabling cross-border medical cooperation.
GSK Hong Kong-Macau GM Nicholas Teo says the data provides supplementary evidence for regulatory filings.
Studies now explore cardiovascular and neurological impacts of vaccines such as flu, shingles and RSV.

1 of 1

Story summary

GSK is using Greater Bay Area patient data to accelerate vaccine and cancer drug development.
The data pool covers 88 million residents across 11 cities, enabling cross-border medical cooperation.
GSK Hong Kong-Macau GM Nicholas Teo says the data provides supplementary evidence for regulatory filings.
Studies now explore cardiovascular and neurological impacts of vaccines such as flu, shingles and RSV.